NxStage Medical, Inc.  

(Public, NASDAQ:NXTM)   Watch this stock  
Find more results for NXTM
+0.25 (1.37%)
After Hours: 18.51 0.00 (0.00%)
May 24, 4:28PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 18.26 - 18.56
52 week 13.47 - 22.60
Open 18.35
Vol / Avg. 0.00/493,036.00
Mkt cap 1.21B
P/E     -
Div/yield     -
EPS -0.17
Shares 64.39M
Beta 0.30
Inst. own 102%
Aug 4, 2016
Q2 2016 NxStage Medical Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
May 26, 2016
NxStage Medical Inc Annual Shareholders Meeting - 10:00AM EDT - Add to calendar
May 20, 2016
NxStage Medical Inc Annual Shareholders Meeting (Estimated)
May 5, 2016
NxStage Medical Inc at Deutsche Bank Health Care Conference
May 4, 2016
Q1 2016 NxStage Medical Inc Earnings Release
May 4, 2016
Q1 2016 NxStage Medical Inc Earnings Call - Webcast
Mar 16, 2016
NxStage Medical Inc at Barclays Global Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin -2.00% -4.84%
Operating margin -1.09% -4.35%
EBITD margin - 4.79%
Return on average assets -2.32% -5.27%
Return on average equity -2.65% -8.03%
Employees 3,600 -
CDP Score - -


350 Merrimack St
LAWRENCE, MA 01843-1748
United States - Map
+1-978-6874700 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


NxStage Medical, Inc. is a medical technology company. The Company is engaged in the development, manufacturing and marketing of products and services for patients suffering from chronic or acute kidney failure. The Company operates through three segments: System One, In-Center and Services. It offers its products and services to various markets, such as home, critical care and in-center. The System One segment is engaged in the sale and rental of the System One and PureFlow SL dialysate preparation equipment, and the sale of disposable products in the home and critical care markets. The In-Center segment is engaged in the sale of blood tubing sets and needles for hemodialysis, primarily for the treatment of end-stage renal disease (ESRD) patients at dialysis clinics, and needles for apheresis. The Services segment offers dialysis services provided to patients at its NxStage Kidney Care dialysis centers.

Officers and directors

Robert G. Funari Independent Chairman of the Board
Age: 67
Bio & Compensation  - Reuters
Joseph E. Turk Jr. President
Age: 48
Bio & Compensation  - Reuters
Jeffrey H. Burbank Chief Executive Officer, Director
Age: 53
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Matthew W. Towse CPA Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
Age: 53
Bio & Compensation  - Reuters
Robert S. Brown President of NxStage Kidney Care
Age: 57
Bio & Compensation  - Reuters
Winifred L. Swan J.D. Senior Vice President, General Counsel
Age: 51
Bio & Compensation  - Reuters
Daniel A. Giannini CPA, Independent Director
Age: 65
Bio & Compensation  - Reuters
Earl R. Lewis Independent Director
Age: 72
Bio & Compensation  - Reuters
Jean K. Mixer Independent Director
Age: 48
Bio & Compensation  - Reuters
Craig W. Moore Independent Director
Age: 71
Bio & Compensation  - Reuters